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ABSTRACT Epidermal growth factor (EGF) receptor (EGFR) modulates mitosis and apoptosis through signaling by its high-
afﬁnity (HA) and low-afﬁnity (LA) EGF-binding states. The prevailing model of EGFR activation—derived from x-ray
crystallography—involves the transition from tethered ectodomain monomers to extended back-to-back dimers and cannot
explain theseEGFRafﬁnities or their different functions. Here, we use single-molecule Fo¨rster resonant energy transfer analysis in
combination with ensemble ﬂuorescence lifetime imaging microscopy to investigate the three-dimensional architecture of HA and
LA EGFR-EGF complexes in cells by measuring the inter-EGF distances within discrete EGF pairs and the vertical distance from
EGF to the plasma membrane. Our results show that EGFR ectodomains form interfaces resulting in two inter-EGF distances
(;8 nm and , 5.5 nm), different from the back-to-back EGFR ectodomain interface (;11 nm). Distancemeasurements fromEGF
to the plasma membrane show that HA EGFR ectodomains are oriented ﬂat on the membrane, whereas LA ectodomains stand
proud from it. Their ﬂat orientation confers on HA EGFR ectodomains the exclusive ability to interact via asymmetric interfaces,
head-to-head with respect to the EGF-binding site, whereas LA EGFRs must interact only side-by-side. Our results support a
structural model in which asymmetric EGFR head-to-head interfaces may be relevant for HA EGFR oligomerization.
INTRODUCTION
The epidermal growth factor (EGF) receptor (EGFR) belongs
to the ErbB family of transmembrane receptor tyrosine
kinases responsible for the signaling pathways leading to cell
proliferation, differentiation, migration, and apoptosis (1–3).
A long-standing puzzle regarding EGFR signaling is the
underlyingmechanism conferring distinct physiological roles
on the high-afﬁnity (HA) and low-afﬁnity (LA) receptors
detected by Scatchard analysis (4,5). HA EGFRs constitute
,5% of cell surface EGFRs in most cell lines (6), and their
afﬁnity for EGF appears to be modulated by interactions
occurring at the plasma membrane and/or the inner side of the
membrane (7,8). HA EGFRs control all the early cell re-
sponses to EGF (4). These include inositol phosphate pro-
duction, release of Ca21 from intracellular stores, rise in
intracellular pH, activation of protein kinase C, induction of
the c-Fos protooncogene, and alterations in cell morphology.
LA complexes constitute.95%of surface EGFRs and appear
to have a role in hyperproliferation and apoptosis (9,10).
EGFR therefore can behave as two different receptors—
which both bind certain growth factors, such as EGF—but are
also selectively activated by other ligands (11).
The bimodal function of EGFR in the cell is not yet under-
stood. Expressed as a single translation product (2), wild-type
EGFR is the prototype receptor tyrosine kinase molecule,
with an ectodomain that binds EGF with a 1:1 stoichiometry
(12,13), connected to its cytoplasmic tyrosine kinase domain
by a single membrane-spanning sequence (2). EGFR activa-
tion is triggered by the binding of growth factor and is
mediated by still poorly understood interreceptor ectodomain
interactions, which ultimately bring neighboring receptor
kinase domains together to allow allosteric transphosphoryl-
ation and the recruitment of cytoplasmic effector molecules
(14). A better understanding of the interactions between ecto-
domains has arisen fromx-ray crystal structures of solubilized
ectodomain fragments. These have revealed an autoinhibited/
tetheredmonomer, an extended ‘‘back-to-back’’ truncated dimer
with two ligands bound at opposite outer sites (hence termed
‘‘back-to-back’’) and a weaker, asymmetric ‘‘head-to-head’’
dimer with two ligands centrally located between ectodo-
mains (12,13,15). Among the dimers, the back-to-back struc-
ture is favored as biologically relevant because it displays
a much stronger interface between EGFR monomers (12).
The prevailing model of EGFR activation derived from
the tethered and extended back-to-back structures, which
involves ligand-mediated EGFR dimerization, has proven
insufﬁcient to explain the different EGFR afﬁnities or their
signaling functions. It was initially thought that these two
structures could explain the high and low ligand-binding
afﬁnities of EGFR because in the tethered monomer only one
contact is made—between ligand and subdomain I—in the
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receptor ectodomain, whereas in the dimer each ligand makes
contact with both subdomains I and III (12,13). However, the
model predicts EGF-binding kinetics that is inconsistent with
a wealth of experimental data from cells and has been found
to be consistent only with kinetic data from a single LA EGFR
population (4,6,16–19). The kinetics of HA EGF-binding are
not yet understood (20).
Cell-based evidence also suggests that additional EGFR
ectodomain interfaces, other than the back-to-back arrange-
ment, might be involved in EGFR activation. Fo¨rster reso-
nance energy transfer (FRET) microscopy, a well-established
spectroscopic ruler to measure intermolecular distances in the
range 2–10 nm (21), has consistently shown ensemble-
averaged FRET between ﬂuorophores bound to the N-termini
of EGF ligands bound to cell surface EGFR (22–26). The
presence of ensemble-averaged FRET in cells was initially
believed to represent the transition fromLAEGFRmonomers
to HA dimers, interpreted in the context of a two-state non-
FRET/FRET transition (22,23).However, after the realization
that the preferred (back-to-back) crystallographic dimer would
show inter-EGF distances of ;11 nm, i.e., not detectable by
FRET, two alternative models of EGFR activation in cells
have since been proposed. In one, the presence of FRET in
cells was explained by the presence of higher-order oligomers
of back-to-back dimers that—in the context of crystallo-
graphic data—would be formed by asymmetric head-to-head
EGFR ectodomain interactions. These head-to-head interac-
tions would result in short distances between the N-termini of
the two bound EGF molecules of ,5 nm (25). In the second
model, FRET was combined with submicron EGFR aggrega-
tion measurements to propose a dimer-to-tetramer transition
incorporating an alternative EGFR ectodomain arrangement
(24). The tetramers were generated through side-by-side con-
tacts between two adjacent back-to-back dimers, for which
there is no crystallographic evidence, with short (;4 nm)
inter-EGF distances. However, the relevance of these models
to the activation mechanism of HA EGFRs needs to be in-
vestigated because the measurement detection limits required
the use of high EGF concentrations (10–50 nM) that resulted
in large, nonphysiological fractions (50%–97%) of the LA
EGFR population—which constitute .90% of cell surface
receptors—being occupied byEGF (24,25,27). Depending on
the cell phenotype, environmental conditions, and receptor
occupancy, EGFR can initiate different signals through selec-
tive activation of its two afﬁnity states (10,11). Correlations
have been shown between enhanced HA signaling and tumor
invasiveness (28). A better understanding of the nature of the
HA and LA EGFRs will therefore provide new insights into
the mechanisms of EGFR signaling in normal and diseased
cells.
In this study, we have investigated the differences in the
structural arrangements of HA and LA EGFR-EGF com-
plexes in A431 cells, an epithelial tumor cell line that ex-
presses high levels of surface EGFRs (1–2 million receptors
per cell) (29) of which 2%–12% show HA for EGF (KD ,
1 nM) (4). A431 cells were chosen because they are one of the
best characterized cell lines with a high level of EGFR expres-
sion. Comparative studies have shown that A431 shares early
characteristics in signal transduction with other cell lines that
express 1%–10% EGFR on the surface, including having HA
and LA receptor populations (crucial to this study) (4), dy-
namic signaling ampliﬁcation (30), degrees of oligomerization
(31), localization to rafts (32), Ca21 signaling (4), InsP3 and
PLC-g pathways (33), adaptor recruitment (34), and STAT (sig-
nal transducer and activator of transcription) activation (35).
Furthermore, A431 cells are ideal for studying EGFR sig-
naling in disease states. Overexpression of EGFR is common
in human squamous cell carcinomas, some of which express
even more receptors than A431 cells, and ampliﬁcation of the
EGFR gene has also been observed in other tumor types and
correlated with poor prognoses in breast and other cancers
((36) and references therein). In women, EGFR overex-
pression is thought to play a critical role in tumor etiology and
progression. Furthermore, EGFR overexpression is associated
with disease recurrence and decreased patient survival (37).
We ﬁrst used single-molecule FRET analysis to survey the
inter-EGFdistanceswithin pairs of EGFmolecules that can be
found on the surface of A431 cells. Single-pair FRET mea-
surement has the advantage of reporting speciﬁc distances
without the need to invoke a particular model and decon-
voluting ensemble-averaged FRET data. It also has the
advantage of allowing the use of lowEGF concentrations (,1
nM) and hence small fractions of LA EGFR occupancy,
relevant to physiological conditions. We then compared the
three-dimensional (3D) architecture of HA and LA complexes
using ﬂuorescence lifetime imaging microscopy (FLIM) and
FRET to measure the distance from EGF molecules to the
plasma membrane. Starting from the known structures of
solubilized EGFR monomers and dimers, we constructed
models of EGFR oligomers consistent with the FRET-derived
in vivo inter-EGF distances and ectodomain orientations with
respect to the plasma membrane. This has revealed differ-
ences in the quaternary structures of HA and LA EGFRs.
MATERIALS AND METHODS
Cell culture
A431 cells were purchased from the European Collection of Animal Cell
Cultures and cultured in Dulbecco’s modiﬁed Eagles medium without
phenol red, supplemented with 10% fetal bovine serum, 2 mM glutamine,
and 1% penicillin/streptomycin (all Invitrogen, Carlsbad, CA) at 37C in the
presence of 5% CO2 in air. A431R cell media were supplemented with PD
153035 to block EGFR tyrosine kinase activity (38).
Binding afﬁnity of EGFCy3
A431 cells were seeded into dishes, cultured as described above, and, when
the cultures reached 70%–80% conﬂuency, deprived of serum overnight.
Cells were chilled by incubation on ice at 4C for 20 min. Duplicate samples
of cells were treated with ice cold 20 nM EGFCy3 or with a 1:1 mixture of
10 nM EGFCy3 and 10 nM murine EGF (mEGF) for 2 h at 4C. Excess EGF
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was removed, and cells were ﬁxed with 1% paraformaldehyde at room
temperature for 10 min. Cells were imaged with an inverted ﬂuorescence
microscope (Axiovert 25; Zeiss, Thornwood, NY) using a 12 bit digital
camera (C7780 3CCD; Hamamatsu, Japan). For each treatment, total ﬂuo-
rescence intensities from 30 conﬂuent areas were measured and the mean
and standard deviation calculated.
Phosphorylation of EGFR by EGFCy3 and EGFCy5
at low temperatures
A431 cells were seeded into wells of a six-well plate, cultured as described
above, and, when the cultures reached;50% conﬂuency, deprived of serum
for 5 h. Cells were then treated for 2 h with either phosphate buffer saline
(PBS) or 20 nM mEGF (diluted in PBS; Peprotech, Rocky Hill, NJ) at room
temperature and at 4C, or with 20 nM mEGFCy3or mEGFCy5 (Cambridge
Research Biochemicals, Cleveland, OH; using mEGF from Peprotech and
CyDyemonoreactive esters fromAmershamBiosciences, Buckinghamshire,
UK) at 4C.Whole cell lysates were prepared by adding 50mL of boiling 23
laemmeli sample buffer (12% sodium dodecylsulfate (SDS), 36% glycerol,
150 mM Tris at pH 6.8, 0.01% bromophenol blue) with 100 nM sodium
ﬂuoride, 1 mM sodium orthovanadate, and 100 mM dithiothreitol to each
well. Cellular proteins were separated by SDS-polyacrylamide gel electro-
phoresis in a 6%acrylamide gel using themethod by Schagger and von Jagow
(39) and transferred onto Hybond-LFP (poly(vinylidene diﬂuoride)) mem-
brane (Amersham Biosciences) using semidry transblot apparatus (BioRad,
Hercules, CA) according to the manufacturer’s instructions. The membrane
was blocked and probed with antiphosphotyrosine (clone 4G10; Upstate,
Lake Placid, NY) and then stripped (62.5 mM Tris at pH 6.7, 2% SDS, 0.8%
b-mercaptoethanol, incubated at 60C for 1 h), blocked, and reprobed with
antivinculin (a gift from Bipin Patel, University of Leicester, UK) according
to the manufacturer’s instructions. Primary antibodies were detected using
horseradish peroxidase conjugated anti-mouse antibody (Jackson Immuno
Research Laboratories, West Grove, PA). The membranes were developed
using enhanced chemiluminescence (West Pico chemiluminescent substrate;
Pierce, Rockford, IL) onto x-ray ﬁlm (Kodak, Rochester, NY).
Preparation of samples for single-molecule
microscopy measurements
Measurements in ﬁxed cells
A431 cells were seeded onto glass-bottomed dishes, cultured as described
above, and,when the cultures reached 60%–70%conﬂuency, deprivedof serum
for 16 h. Cells were incubated in PBS supplemented with 1 mMHEPES at pH
7.4 for 2.5 h at 37C in the presence of 5% CO2 in air. Cells to be ﬁxed before
EGF binding were treated with 1% paraformaldehyde for 10 min at 18C,
washed, and stored at 4C before labeling 16–24 h later. Cells to be ﬁxed after
EGF binding were chilled to 4C. EGFCy3 and EGFCy5 (Cambridge Research
Biochemicals, using mEGF from Peprotech and CyDye monoreactive esters
from Amersham Biosciences) solutions were prepared in PBS supplemented
with 1 mMHEPES at pH 7.4 and 0.1% bovine serum albumin (BSA) chilled to
4C. MEGF has only one reactive amino residue (at the N-terminus) and was
labeled at a ratio of exactly 1:1 protein/dye, as conﬁrmed by high performance
liquid chromatography and mass spectrometry. Cells were labeled with 1:1
EGFCy3/EGFCy5 solutions, at concentrations of 0.1–1.0 nM, for 2 h at 4C.Cells
to be ﬁxed after EGF binding were treated with paraformaldehyde as described
above, washed, and stored at 4C. EGFR phosphorylation was conﬁrmed by
Western blot (Fig. 1 B). Cells were imaged on the same day as EGF labeling.
Measurements on LA receptors in ﬁxed cells
A431 cells were seeded and serum-starved as described above. Cells were
incubated in PBS supplemented with 1 mM HEPES at pH 7.4, 0.1% BSA,
and 200 nM anti-EGFR clone 108 (gift from KathrynM. Ferguson) for 4 h at
4C, to block EGF binding to HA receptors (40). The cells were then ﬁxed
and treated with EGF, or vice versa, according to the protocol described above.
Measurements in live cells
A431 cells were seeded onto glass coverslips and cultured as described
above until ;60%–70% conﬂuent. On the day of the experiment cells were
incubated in antiinternalization buffer (PBS supplemented with 1 mM
HEPES at pH 7.4, 10 mM sodium azide, 10 mM deoxy-d-glucose, and 0.1%
BSA (23)) at 37C for 20 min in the presence of 5% CO2 in air. Cells were
labeled with 0.2 nM EGFCy3 and 1 nM EGFCy5 in antiinternalization buffer
at 18C and imaged ;10 min later using the single-molecule microscope.
Preparation of samples for confocal microscopy
and FLIM
Measurement of distances from EGF to the cell surface for
HA receptors
A431 cells, treated as described above, were incubated with 5 mMDiI (1,19-
dioctadecyl-3,3,39,39- tetramethylindocarbocyanine perchlorate) (Vybrant
cell-labeling solution, Invitrogen) diluted in serum-free culture media at
37C for 15 min to label the plasma membrane. Cells were then incubated in
PBS supplemented with 1 mM HEPES at pH 7.4, 0.1% BSA, and 200 nM
Anti-EGFR clone 2E9 (Caltag-MedSystems, Carlsbad, CA) for 4 h at 4C to
block EGF binding to LA receptors (4). Cells to be ﬁxed before EGF binding
were treated with 1% paraformaldehyde for 10 min at 18C. Cells were
labeled with 100 nM EGFFluorescein (mEGF conjugated at its N-terminus with
ﬂuorescein, Invitrogen) diluted in PBS supplemented with 1 mM HEPES at
pH 7.4 and 0.1% BSA for 2 h at 4C. Cells to be ﬁxed after EGF binding
were treated with paraformaldehyde as described above, washed, and stored
at 4C. Cells were imaged on the same day.
Measurement of distances from EGF to the cell surface for
LA receptors
The above protocol was followed to prepare these samples, except that the
cells were not treated with anti-EGFR clone 2E9 but were chilled on ice at
4C for 20 min before treatment with EGF.
Measurement of mean inter-EGF distances for HA
and LA receptors
The protocol used to prepare these samples has been previously reported (23).
Preparation of samples to measure the mean FRET
efﬁciency of noninternalized receptor populations using FLIM
A431 cells were labeled with 100 nM of unlabeled EGF, allowed to
internalize EGF-EGFR for 15 min at 37C, then cooled to 4C to block
EGFR recycling to the cell surface. This was followed by the removal of
unlabeled EGF remaining on the cell surface by an acid wash (41).
Noninternalized EGFRs were labeled with a 1:2 mixture of EGFAlexa488 and
EGFErythrosin at 4C.
Single-molecule ﬂuorescence microscopy
The single-molecule total internal reﬂection ﬂuorescence (TIRF) microscope
used was as previously reported (42). Brieﬂy, samples were placed in a
custom-built TIRF microscope and excited with 1 mW at 532 nm. The resul-
tant ﬂuorescence was divided into orthogonal polarizations and two wave-
length bands corresponding to Cy3 and Cy5 emission (Quad View, Roper
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Scientiﬁc, Tucson, AZ), giving four images on the charge-coupled device
(CCD) (iXon; Andor, South Windsor, CT) of the same ﬁeld of view, but
differing in spectral and polarization content. Images were acquired at;3 Hz
with an integration time of 277 ms.
Single-molecule data analysis
Fluorescent spot locations in time-integrated image series were identiﬁed
using custom-written IDL routines (incorporating some from Crocker and
Grier (43) and Crocker and Weeks (44)). The average image for a data set
was calculated and band-pass ﬁltered to reduce noise on the scale of 1 pixel
and remove smooth variations on scales greater than the spot size. Peaks in
this ﬁltered image were then used as potential ﬂuorescent spot positions. The
background for each frame was calculated by smoothing it on a scale larger
than the spot size while masking out the region around all spot positions.
Intensity time traces for the two wavelengths were calculated by integrating
the unﬁltered background-subtracted images in each channel around each
spot position throughout the time series. FRET efﬁciencies were calculated
allowing for bleed through (3%) and following calibration as reported
previously (42) during selected time intervals. Extensive manual ﬁltering of
the obtained traces ensured that only reliably measured features were
retained.
Random noise in the images (e.g., detector readout noise, Poisson
counting statistics) means that individual background-subtracted intensity
measurements from the images can be negative (see Fig. 3 B). Negative
intensities are clearly unphysical but are correctly handled by modeling the
underlying intensity correctly over a series of frames. The simplest case,
where the intensity is assumed to be constant, is to take the mean and
standard deviation of intensities. We did this to measure the donor and
acceptor intensity distributions in the selected frame ranges. From these we
calculated the FRET efﬁciency.
FLIM microscopy
For FRET between EGF and the membrane, ﬂuorescence decays were
recorded using a frequency-doubled laser (Coherent, Santa Clara, CA; l ¼
460 nm, 76 MHz repetition rate). Fluorescence decays were collected
between l ¼ 480 nm and l ¼ 520 nm, where there was no bleed through
from the acceptor. FRET efﬁciencies and distances were calculated as
described previously (45). For the mean FRET efﬁciency of low- and high-
afﬁnity receptors, the method was as reported previously (23).
Anisotropy measurements
The steady-state anisotropies of the ﬂuorophores conjugated to EGF were
determined using a Jobin Yvon (Longjumeau, France) Fluorlog-3 steady-
state ﬂuorimeter. Solutions of EGFCy3, EGFCy5, and EGFFluorescein were pre-
pared in 99% glycerol and PBS at concentrations of 0.1–1 mM and excited
with polarized light at 552 nm, 640 nm, and 445 nm, respectively. Time-
resolved anisotropy decays were collected as previously described (23).
FIGURE 1 (A) Afﬁnity of labeled and unlabeled EGF for binding to EGFR (see Materials and Methods). Since the intensity approximately halves when the
proportion of EGF labeled is also halved, labeling does not signiﬁcantly affect the EGF binding afﬁnity to EGFR. (B) Merged time-integrated donor (EGFCy3;
green) and acceptor (EGFCy5; red) images of a sample of A431 cells exposed to 0.25 nM EGFCy3 and 0.5 nM EGFCy5. (C) White light transmission image
corresponding to the same area as in B. (D) Western blots of whole cell lysates to show phosphorylation of EGFR in resting and EGF-stimulated A431 cells.
A431 cells were treated for 2 h with either PBS or 20 nM mEGF (mEGF, diluted in PBS) at room temperature or with PBS, 20 nM mEGF, mEGFCy3, or
mEGFCy5 at 4C. Probing with an antiphosphotyrosine antibody shows EGFR is phosphorylated when A431 cells are stimulated with EGF, EGFCy3, or
EGFCy5at 4C. The blot was subsequently probed with antivinculin as a loading control showing an approximately equal amount of total protein in each lane.
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Calculation of Fo¨rster radius for EGF derivatives
in solution
We evaluated Fo¨rster radius (R0) from EGF
Cy3 ﬂuorescence and EGFCy5
absorption solution measurements at the 649 nm Cy5 absorption maximum,
using an absorption coefﬁcient of 250,000M1cm1 and an orientation factor
of k2¼F6 14%. This error in k2 was taken to be the same as that calculated
by Yasuda et al. (46) because the semicone angles of the subnanosecond
wobble (fc) of each ﬂuorophore were very similar to those reported therein.
fc was calculated to be ;28 for Cy3 and ;38 for Cy5, using rN¼
r0½1=2cosucð11cosucÞ2;where rN and r0 are the experimentally determined
residual and limiting anisotropies, respectively. The refractive index was
assumed to be 1.33. The error in R0 was mainly from k
2 and was estimated
usingDR0 ¼ R0Dðk2Þ=6k2 (46). R0 was thus calculated to be 5.7 nm6 14%,
consistent with previous results (47).
For dyes with a ﬂuorescence lifetime t . 1 ns, such as ﬂuorescein, the
anisotropy decay when bound to protein in solution is typically multi-
exponential (23), i.e., rðtÞ ¼ b1et=u11b2et=u21rN. fc was hence calcu-
lated from rN, preexponential terms b1, b2, and correlation times f1, f2 for
EGFFluorescein in PBS (Table 1). The equivalent residual anisotropy r9N after
depolarization due to rotation of the dye with respect to EGF is r9N¼
½b2=ð11t=f2Þ1rN; leading to fc ¼ 53. This is equivalent to a donor
depolarization factor of 0.04 and an error in k2 ¼ F of ,10% (48).
Analysis of crystal structures
Crystal structures were manipulated and analyzed using programs from
Collaborative Computational Project No. 4 (49). Coordinates were down-
loaded from the Protein Data Bank (50). The structures were analyzed and
distances calculated using Coot (51), and ﬁgures were prepared with
CCP4mg (52). The PISA web service (53) was used to analyze interfaces
between EGFR monomers. The normal modes of the EGFR dimer were
estimated using the elNemo web service (54).
RESULTS
Single-pair FRET analysis of EGF-EGF distances
in EGFR complexes
EGF labeled at its N-termini with Cy3 and Cy5 dyes (denoted
EGFCy3 and EGFCy5) was added to the medium of A431 cells
in culture as FRET donor-acceptor pairs. Addition of dye to
the N-terminus of EGF did not modify the afﬁnity of EGF for
EGFR (Fig. 1 A). Cy3 and Cy5 are ideal for single-pair FRET
measurements as they possess well-separated emission spec-
tra, a signiﬁcant overlap between donor emission and acceptor
absorption, comparable quantum yields that can result in
easily identiﬁable anticorrelated donor and acceptor signal
ﬂuctuations, and good photostability (55). We used ﬁnal
concentrations of a 1:1 mixture of EGFCy3 and EGFCy5 of
0.1–1 nM that are close to physiological conditions for EGFR
occupancy (i.e., #50% HA and #10% LA EGFR bound to
EGF) and optimal for single-molecule microscopy.
The occupancy fraction Fwas calculated using F¼ [EGF]/
[EGF] 1 KD, where KD is the dissociation constant. Given
that the Fo¨rster radius of the Cy3/Cy5 pair is 5.7 nm, FRET
will only occur if EGFCy3 and EGFCy5 are within,10 nm of
each other. Fig. 1 B is a time-integrated ﬂuorescence image
showing an example of the ﬂuorescent spots that appear on the
cell surfacewhenCy3was selectively excited at 532 nmunder
total internal reﬂection conditions and emissions from Cy3
and Cy5were simultaneously imaged onto different areas of a
CCD camera (42); Fig. 1C is a white light transmission image
of the same area. The number of spots is lower than the
nominal density because, for example, many receptors are not
excited due to cell surface rufﬂing placing them outside the
evanescent ﬁeld and photobleaching before data acquisition
started. On excitation of donor EGFCy3 the occurrence of
FRET is shown by a decrease in donor ﬂuorescence intensity
and the simultaneous appearance of sensitized acceptor EGFCy5
ﬂuorescence. The ﬂuorescence intensity versus time traces
associated with the spots displayed typical characteristics of
single-molecule ﬂuorescence data (47), including discrete
bleaching steps and blinking in the donor and acceptor
channels.
To investigate the FRET efﬁciencies that can be found in
the EGFR-EGF complexes that form in A431 cells with
physiological EGF concentrations, we used 12 samples of
A431 cells. Six were ﬁrst lightly ﬁxed to trap EGFR in
inactive conﬁgurations and then exposed to EGF. The other
six samples were ﬁrst exposed to EGF while held at 4C to
inhibit ligand-induced EGFR internalization (23), then ﬁxed
to trap EGFR complexes in active conﬁgurations. Given that
the FRET efﬁciency determined by FLIM measurement is
identical in the absence and presence of ﬁxative (Supplemen-
tary Fig. 1), we conclude that FRET values at the plasma
membrane are not affected by the light ﬁxation. The low
temperature did not inhibit receptor phosphorylation, as
determined by Western blot (Fig. 1 D). We could not detect
any difference in FRET at the single-molecule level between
cells exposed to EGF exposure at 4C or at room temperature
(42). There is awealth of evidence that signaling byEGFRcan
still proceed at 4C—e.g., incubation with EGF at 4C does
not affect the lateral diffusion dynamics of complexes at the
cell surface (56,57), EGFR signaling to the level of Ras
activation is also efﬁcient in the cold (58), and immunoblots
using antibodies against phosphotyrosine demonstrated that
EGF treatment of intact cells increases the phosphotyrosine
content of at least six EGFR substrates within 5 s at 4C
(59)—which suggests that ligand receptor complexes form as
normal at the cell surface at this temperature. Fig. 1 D also
TABLE 1 Experimental steady-state anisotropy values
and time-resolved anisotropy decay parameters
A* Free Cy3 Free Cy5 EGFCy3 EGFCy5 EGFFluorescein
PBS 0.230 0.194 0.271 0.210 0.077
99% Glycerol 0.382 0.388 0.313z
By b1 f1 b2 f2 rN
EGFFluorescein 0.20 0.11 0.06 4.58 0.04
The measurement errors are ;1%.
*Experimental steady-state anisotropy values for free ﬂuorophores and EGF
derivatives in solution used to calculate the errors in FRET-derived inter-
EGF distances.
yTime-resolved anisotropy decay parameters of EGFFluorescein in PBS.
zExcited away from absorption maximum at 445 nm.
Different Structures for HA and LA EGFRs 807
Biophysical Journal 94(3) 803–819
shows that EGFCy3 and EGFCy5 activate EGFR as efﬁciently
as native EGFR.
The features identiﬁed on the cell surface were classiﬁed
into three categories: i) spots that displayed clear FRET,
deﬁned as having sensitized ﬂuorescence intensity distinctly
above the bleed through from the donor channel (;3%); ii)
spots that displayed very low FRET and/or donor-only
ﬂuorescence; and iii) overlapping, out-of-focus, weak inten-
sity and otherwise unreliable spots (all rejected). From
category (i) we selected spots showing clear abrupt bleaching
steps that were well separated from other features, within a
diffraction-limited size and had FRET efﬁciency traces with a
signal/noise ratio greater than ;3. For the selected spots,
examples of which are shown in Fig. 2, A–F, we built a
histogram of FRET efﬁciency values for intervals between
bleaching steps in individual spots (Fig. 3 A). According to
Fo¨rster theory, the FRET efﬁciency increases with the inverse
sixth power of the donor-acceptor separation (21). From the
anisotropy data in Table 1 and assuming k2 ¼ F, the errors
in the distances shown are 614% for single pair FRET (see
Materials and Methods).
Two broad clusters of low and high FRET efﬁciencies were
observed in the EGFR complexes, whether cells were ﬁxed
before exposure to EGF (Fig. 3A, red) or after (Fig. 3A, blue).
Given that there are 50–1,000 EGFRs per mm2 on the cell
surface of A431 cells (26,56), we checked whether the inter-
actions shown in Fig. 3 A could also be found in HeLa cells,
which have an estimated density of ,10 receptors per mm2
(assuming ;50,000 EGFRs per cell and a cell diameter of
;20 mm). Since we could ﬁnd examples of spots showing
high FRET and low FRET values on the surface of HeLa cells
(Supplementary Fig. 2), we conclude that random colocaliza-
tion of receptors due to EGFR overexpression cannot explain
the FRET results shown in Fig. 3 A.
Fig. 3, B and C, shows examples of long (9 nm) and short
(4 nm) inter-EGF distances. Besides the broadening intro-
duced by the inherent614% error in the distance calculation
from uncertainties in the value of the orientation factor, some
additional broadening of the FRET efﬁciency distribution
can also be expected from the breakdown of the point-dipole
approximation at distances comparable to the size of the dyes
(2 nm) (60). However the FRET efﬁciency clusters in Fig. 3
A are so far apart that they must report on at least two struc-
turally different ectodomain interfaces, which place EGF-
binding sites long (;8 nm) and short (,5.5 nm) distances
apart. The data in Fig. 3 A provide the ﬁrst direct evidence of
high-FRET interfaces between single EGF pairs in EGFR-
EGF complexes in cells. We were unable to explain these
distances in light of the back-to-back EGFR dimer (Fig. 3 D)
even after applying extreme deformations to this crystal
structure—for example, by changing the angle between
domains I and III and domain II and/or applying extreme
perturbations along low frequency normal modes—as the
predicted distances between N-termini always remain .9
nm (M. D. Winn, unpublished observations). The occurrence
of long and short distances in single-pair interactions (Fig. 3
A, lower), therefore, shows that EGFR ectodomains can form
at least two interfaces different from the crystallographic back-
to-back interface, not just the one assumed by simple FRET/
non-FRET models (22,24,25). Signiﬁcant FRET was observed
independent of whether cells were ﬁxed before exposure to
EGF (inactive states) or vice versa (active states), consistent
with some unliganded EGFRs being constitutively oligomer-
ized on the cell surface, as previously suggested (23,26,47).
Multiple ﬂuorescence bleaching steps by the donor and/or
acceptor were also observed alongside many examples of
single-step photobleaching (Fig. 3 A, lower). Examples are
shown in Fig. 2, E and F, and have been collated in Table 2,
the latter including additional data from live samples. These
multiple steps report on groups of EGFRs colocalized within
spots, i.e., within the point spread function (PSF) of the
microscope (full width at half-maximum ;500 nm). Given
that spots can also contain any number of nonﬂuorescent,
unliganded EGFRs and/or unpaired EGFR-EGFCy5 units, the
number of bleaching steps actually reports on the minimum
number of receptors colocalized in a sub-500 nm diameter
area on the cell surface (Table 2). This ﬁnding is consistent
with previous reports which showed that EGFR can aggregate
within microclusters (24,26). Considering the low density of
spots formed at the low EGF concentrations employed, the
probability of receptor groups colocalizing by chance within
the PSF of the microscope is small. Given that spots remain
intact while slowly diffusing in the plasma membrane (Sup-
plementary Fig. 3), our ﬁndings suggest that receptors are
stably held together by interactions at the plasma membrane,
such as by oligomerization or lipid rafts smaller than the PSF
of the microscope (8).
We illustrate many of the features of the different modes
of interactions between EGFR-EGF complexes described by
Fig. 3 A in an example from live cells (Fig. 3 E). First, we see
several receptors colocalized. The two acceptor ﬂuorescence
steps (D and J in Fig. 3 E) report the presence of two acceptor
EGFCy5 molecules. Therefore, at least one donor EGFCy3
must be transferring energy to the two acceptors during A.
Second, high FRET is demonstrated by the increase in donor
intensity upon the bleaching of one acceptor (D), which is
equivalent to that observed in single unquenched EGFCy3
molecules; the large magnitude of these changes demon-
strates a short inter-EGF separation had existed in this pair
(61). High FRET is observed again as this acceptor ﬂuo-
rescence brieﬂy recovers and bleaches for a second time in
H. During B, a further EGFR-EGFCy3 unit diffuses and be-
comes colocalized with the complex at C. Neither colocal-
ization at C nor the transient dissociation (or blinking) of two
of the three donor EGFR-EGFCy3 units during F changes the
intensity of any of the acceptors, indicating distances .10
nm between these groups. Since the donor ﬂuorescence
intensity that disappears during F (whereas an acceptor
continues ﬂuorescing) is equivalent to that expected from
two ‘‘donor units’’ (one unit being the increase at C), there
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are at least three donors present. We conclude that this spot
contains at least three donors and two acceptors.
FRET analysis of inter-EGF distances in HA and
LA EGFR complexes
Depending on the conditions, such as the donor/acceptor
ratio employed, HA EGFRs have been shown by FLIM
measurement to display mean FRET efﬁciency values be-
tween 0.22 and 0.40 (22,23). Selective EGF saturation-
binding of the HA EGFR population was achieved using a
monoclonal anti-EGFR antibody 2E9 (mAb 2E9) to block
EGF binding to the LA population (4). (The 2E9 antibody
does not disturb binding to HA EGFRs (4).) Our ensemble
FRET measurements reproduce these results (Fig. 4 A). We
conjugated EGF to Alexa 488 (donor) and Erythrosin
(acceptor) (EGFAlexa488 and EGFErythrosin) and exposed
A431 cells to saturating concentrations of mAb 2E9 to
block EGF binding to the LA population (4) followed by a
1:2 mixture of EGFAlexa488 and EGFErythrosin at a ﬁnal EGF
FIGURE 2 Examples of single-pair
FRET traces. (A) A single-donor photo-
bleaching step. FRET efﬁciency 0.16,
standard deviation 0.09. (B) One of two
donors photobleaching. The low intensity
suggests the molecule is out of focus
(away from the peak of the evanescent
ﬁeld). FRET efﬁciencies 0.11 and 0.14,
standard deviations 0.06 and 0.09, respec-
tively. (C) Single strong FRET interac-
tion. FRET 0.84, standard deviation 0.18.
(D) Single interaction with completely
quenched donor. (E and F) Traces show-
ing multiple steps. Fluorescence intensity
versus time traces of donor (blue) and
acceptor (red) ﬂuorophores and temporal
variation FRETefﬁciency (purple). Black
lines andgray error bars showmean6SD
in the marked region. Images show mean
donor and acceptor ﬂuorescence (back-
ground-subtracted) during time intervals
as marked.
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FIGURE 3 (A) (Upper) Distribution of FRET efﬁciencies and equivalent separations in A431 cells exposed to EGF concentrations (0.1–1 nM) of a 1:1
mixture of EGFCy3 and EGFCy5. (Red) Cells pre-ﬁxed with 1% paraformaldehyde and then exposed to EGF. (Blue) Cells ﬁrst exposed to EGF at 4C and then
ﬁxed; the combined data are shown in black. (Lower) The table speciﬁes for each FRET efﬁciency value in the histogram the minimum number of EGFRs in
the associated spot (determined from the number of EGFCy3 and/or EGFCy5 photobleaching steps). (B and C) Traces shown as described in Fig. 2. (D) Model of
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concentration of 100 nM at 4C. At this EGF concentration,
most HA EGFRs are bound to EGF (23). The Alexa 488/
Erythrosin FRET pair is ideal for ensemble FLIM-FRET
measurements because the ﬂuorescence lifetime of Alexa
488 is ;10 times longer than that of Cy3, so larger changes
in lifetime are expected for Alexa 488 for the same FRET
efﬁciency values. In addition, the Fo¨rster radius (5.7 nm)
(23) has the same value as the Cy3/Cy5 pair, allowing direct
comparison of ensemble and single-molecule FRET results.
We found the FRET efﬁciency between donor and acceptor
EGF ligands bound to the HA EGFR population to be 0.246
0.05 (Fig. 4 A, blue bar). This, therefore, shows that EGFR
ectodomain interfaces with inter-EGF distances of ,10 nm
are involved in the formation of HA EGFR complexes,
potentially explaining some of the interactions contributing
to Fig. 3 A.
When the binding of EGF to HA EGFRs is not blocked by
mAb 2E9, previous ensemble FRET measurements have re-
turned lower mean FRET efﬁciencies (between 0.05 and 0.18)
than in the conditions when HA EGFRs were selectively
labeled (22,24). In the absence of mAb 2E9, using a 1:2 mix-
ture of EGFAlexa488 and EGFErythrosin at a ﬁnal EGF concen-
tration of 100 nM at 4C, we found a mean FRET efﬁciency
value of 0.16 0.01 (Fig. 4 A, yellow bar). However, in cells
allowed to internalize EGFR-EGF for 15 min at 37C and
then cooled to 4C to block EGFR recycling to the cell
surface, there was no evidence of FRET between donor- and
acceptor-labeled EGFR-EGF complexes that were not inter-
nalized (;60% of the total number) (Fig. 4 A, purple bar).
This shows that receptors displaying FRET on the cell surface
are targeted for downregulation. We also found that FRET is
abolished at the surface of A431 cells by exposing the cells to
the tyrosine kinase inhibitor PD 153035 (i.e., A431R cells)
(38) (Fig. 4 A, green bar) even though the cells still express
the same number of receptors. We therefore conclude that the
interactions at the plasma membrane of A431 cells described
by FRET are biologically relevant.
The larger FRET efﬁciency value observed when only HA
EGFR are allowed to bind EGF (Fig. 4 A) shows that EGFR
ectodomain interfaces yielding high FRET efﬁciencies are
more prevalent in HA complexes. The mean FRET efﬁ-
ciency when both HA and LA EGFR are allowed to bind
EGF must largely reﬂect the FRET value from the LA EGFR
population alone, as the contribution from the HA population
(,10%) is smaller than the error of the measurement (10%)
(Fig. 4 A). However, unlike ensemble FRET measurements
for HA EGFRs, in which the number of EGFRs occupied by
EGF (;7.5 3 104) was comparable to that in the single-
molecule FRET experiments (1–4 3 104 HA EGFR
occupied at 0.1–1 nM (EGF)), the ensemble FRET efﬁciency
value from the LA population (Fig. 4 A) was averaged over
1–2 3 106 EGF-bound receptors, which is 10–1003 larger.
To investigate whether FRET could still be found in LA
EGFRs at low fractions of EGF occupancy, we treated two
samples of A431 cells with saturating concentrations of
monoclonal anti-EGFR 108 (mAb 108) that blocks EGF
binding to the HA population (40) before exposing the cells
to a 1:1 mixture of EGFCy3 and EGFCy5 at a total EGF
concentration of 2 nM. Fig. 4, B and C, shows two examples
of donor-only ﬂuorescence intensity versus time traces from
LA complexes showing one- and two-step photobleaching,
the latter showing that LA EGFR-EGF in A431 cells also
colocalize within the PSF of the microscope consistent with
previous results (26). Although spots showing high FRET
efﬁciency values were relatively harder to ﬁnd, Fig. 4 D
shows two clear examples of high-FRET interfaces in two
LA EGFR complexes. The FRET efﬁciency values corre-
spond to inter-EGF distances of ;4.5 nm. These observa-
tions suggest that LA EGFR ectodomains can also interact at
low EGF occupancy in an arrangement that results in short
inter-EGF distances.
FLIM-FRET measurements of the distance from
EGF to the plasma membrane
To gain insight into the 3D arrangement of the EGFR
ectodomain interfaces shown in Fig. 3 A, we investigated the
distance between EGF conjugated at its N-terminus to donor
ﬂuorescein (EGFFluorescein) and the membrane-labeling ac-
ceptor chromophore DiI in HA and LA EGFR-EGF com-
plexes. The ﬂuorescein-DiI FRET pair was chosen for these
TABLE 2 Number of donor and acceptor molecules and hence
the minimum number of EGFRs per spot determined from the
number of photobleaching steps in the associated donor and












the crystal structure of the ectodomains of an EGFR dimer standing proud (15), based on coordinates of the EGF-EGFR dimer from Ogiso et al. (13). The
ectodomain is divided into four subdomains. Domains I and III (or L1 and L2, large homologous domains) bind to peptide ligands (e.g., EGF, transforming
growth factor-a, amphiregulin, betacellulin, epigen, epiregulin, and heparin binding EGF-like growth factor) (74,75). Domain II (or CR1, cysteine-rich domain
1) includes a dimerization arm, two of which interact to form the back-to-back EGFR-EGFR dimer (12,13). Interactions between domain IVs (or CR2,
cysteine-rich domain 2) of EGFR may also be involved in the back-to-back EGFR-EGFR interface ((76) reviewed in Burgess et al. (77) and Saxon and Lee
(78). (E) Trace showing three donors and two acceptors in one spot.
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measurements because its Fo¨rster radius (3.5 nm) has been
very well characterized in a similar geometry (62). We used
ensemble-averaged FLIM-based FRET measurement be-
cause the concentration of DiI needed to ensure colocaliza-
tion of the membrane probe with EGFR-bound EGF
precluded single-molecule measurement. The DiI was ob-
served to be uniformly distributed across the cell. To study
HA EGFRs, three samples of A431 cells were incubated with
DiI, exposed to a saturating concentration of mAb 2E9 to
block EGF binding to LA receptors (4), and then ﬁxed and
exposed to a saturating concentration of EGF (100 nM).
Three further mAb 2E9-labeled samples were ﬁrst exposed
to EGF at 4C and then ﬁxed. We found that ﬂuorescence
lifetime distributions of EGFFluorescein bound to HA receptors
peaked at much shorter values in samples colabeled with the
DiI acceptor than in samples without acceptor, which did
not show evidence of donor lifetime quenching (Fig. 5 A).
We determined that local membrane acidiﬁcation effects
FIGURE 4 (A) Histograms of ensemble FRET efﬁciencies of HA EGFR populations alone and with LA EGFR in A431 cells, plus the noninternalized EGFR
population in A431 cells and in tyrosine kinase-inhibited A431R cells, using EGFAlexa488, EGFErythrosin, and FLIM. Fluorescence traces showing one step (B)
and two steps (C) in the donor channel. (D) Traces showing high and low FRET efﬁciencies in LA EGFR complexes in A431 cells labeled using a 2 nM 1:1
mixture of EGFCy3 and EGFCy5.
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could not contribute in any way to the observed ﬂuorescence
lifetime shortening (for example, via a change in EGF con-
formation that alters the interactions between EGF and the
probe) (Fig. 5 B). Given that the donor ﬂuorescence was re-
covered on acceptor photobleaching (data not shown), we
conclude that the shortening of the donor lifetime in the
presence of acceptor is due to FRET.
The efﬁciency of FRET was determined from the mean
ﬂuorescence lifetime of donor EGFFluorescein bound to HA
EGFR in the presence and absence of acceptor DiI. From the
anisotropy data in Table 1, the errors in the distances using
the inverse sixth power of the donor-acceptor separation and
the randomized orientation factor k2 ¼ F are 610% (see
Materials and Methods). The observed FRET efﬁciency of
0.5, therefore, shows a peak distance from EGF to the cell
surface of ;3.5 nm 6 10% (Fig. 5 C). This distance is
substantially smaller than that predicted by the back-to-back
dimer model in Fig. 3 D, which, based on the conﬁguration
in the autoinhibited monomer (15), is usually represented
fused with domain IV and standing proud from the mem-
brane (63), giving a distance between the N-terminus of EGF
and the outer surface of the plasma membrane of ;8.2 nm
(Fig. 3 D). This distance comprises 4.3 nm from the EGF
N-termini to a plane containing the EGFR ectodomain
C-termini of the back-to-back dimer crystal structure (from
1ivo, Table 3), plus the length of missing residues 513–621
of domain IV (added by Ogiso et al. (13)). Our FLIM-FRET
measurement shows that ectodomains of HA receptors must
instead lie ﬂat on the plasma membrane, not perpendicularly
as previously thought. For this to occur the hinge region
between domain IV and the transmembrane domain must be
very ﬂexible, consistent with x-ray crystallography predictions
of the high degree of disorder in this region (12,13,15,64).
Since the same distance from EGF to the membrane was found
in pre-ﬁxed cells (Fig. 5 C), we conclude that HA EGFRs are
constitutively oriented ﬂat on the plasma membrane.
FIGURE 5 (A) Mean ﬂuorescence
lifetime distributions of EGFFluorescein
bound to HA EGFRs in A431 cells
whose plasma membrane was labeled
with DiI, for cells ﬁxed with 1%
paraformaldehyde before (red) and af-
ter (blue) binding EGF. Control FLIM
data in the absence of DiI (acceptor) are
shown as dotted lines. Curves corre-
spond to different ﬁelds of view, an
example of which is shown to the right,
and are normalized as photon-weighted
ﬂuorescence lifetime distributions. The
black curves are the normalized sums of
the corresponding unnormalized pho-
ton-weighted ﬂuorescence lifetime dis-
tributions. (B) Fluorescence lifetime of
EGFFluorescein in buffer solution mea-
sured at the range of pH shown. (C)
FRET-derived separation between
EGFFluorescein (donor), bound to HA
EGFRs, and the cell surface decorated
with DiI (acceptor). (D) Fluorescence
lifetime distributions of EGFFluorescein
bound to LA EGFRs (EGF binding to
LA EGFR was blocked using mAb 2E9
(S3)) before (red) and after (blue)
ﬁxation with 1% paraformaldehyde.
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Similarly, we measured the distance between LA EGFR-
EGFFluorescein and DiI probes on the cell surface by incubat-
ing A431 cells with DiI and then exposing them to a saturating
concentration of EGF (100 nM), which, in the absence of
mAb 2E9, labels most HA and LA EGFR binding sites (23).
As described before, the contribution to the measured FRET
efﬁciency from the HA EGFR population (,10% of surface
EGFRs) is negligible. Unlike the HA case, we did not ﬁnd
any evidence of FRET, either in pre-ﬁxed cells or cells ﬁrst
activated by EGF. The absence of FRET is unlikely to be
solely due to preferential labeling by DiI of lipid rafts, which
has been reported in the literature to occur in artiﬁcial mem-
brane preparations (65) because EGFRs colocalize with lipid
rafts (32). Given the magnitude of the ﬂuorescence lifetime
quenching observed for HA EGFRs, a substantial shortening
of the lifetime would therefore have been observed if LA re-
ceptors were similarly oriented ﬂat on the plasma membrane.
However, given that the Fo¨rster radius for this pair is 3.5 nm,
zero FRET efﬁciencies correlate with distances from EGF to
the cell surface .7 nm (Fig. 5 D), showing LA ectodomains
stand proud from the plasma membrane. FLIM-FRET mea-
surement therefore shows that HA and LA EGFRs consti-
tutively have different orientations with respect to the plasma
membrane, consistent with the notion that EGFR afﬁnity is
regulated by the formation of ternary complexes between HA
EGFR and intracellular substrates, a ﬁnding that could also
explain the equilibrium kinetics of EGF binding (66,67).
Crystal structure analysis of ectodomain
interfaces in HA and LA complexes
To investigate possible 3D quaternary structures consistent
with the inter-EGF distances we observed (Fig. 3 A) and the
distances from EGF to the membrane (Fig. 5 C), we surveyed
the EGFR interectodomain interfaces so far described by
x-ray crystallography (Table 3). The back-to-back EGFR dimer
(Fig. 3 D) (12,13) deposited with Protein Data Bank (PDB) ID
codes 1mox and 1ivo provides an interface between the two
EGFR monomers with a large surface area with a negative
solvation Gibbs free energy difference (DG) and a p-value
very close to zero. Alternative weaker interfaces between
EGFRmonomers have also been described (12,13,15) and are
compared here. The weak A:A and weak B:B conformations
contain very weak interfaces, shown by the small surface area
at the contact points. These contacts are not favorable as they
have positive DG values and p-values of greater than 0.5 and
therefore will not be considered further here. Interfaces in an
inactive crystallographic dimer (15), denoted here as head-to-
back and domain II/IV interactions and depositedwith PDB ID
code 1nql, show that these contact points create a reasonable
surface area and a negative DG value.
Finally, the head-to-head conformation contains weak inter-
faces made up of contacts that constitute a small surface area.
The DG value, however, is negative and the p-value slightly
less than 0.5. The distance between the N-termini of bound
ligands is similar for the head-to-head and head-to-back dimer
conformations, 5.0 nm and 5.3 nm, respectively. By modeling
the possible positions of the dye molecules attached to the
N-termini of these ligands, the distance between the chromo-
phores is reduced for the head-to-head conformation and is
predicted to remain similar for the head-to-back conformation.
Similarly, the conformation involving domain II/IV inter-
faces gives a distance of 6.8 nm between the N-termini of
EGF. The observed weak crystal interfaces illustrate possible
interectodomain arrangements that would explain the single-
molecule low-FRET and high-FRET clusters (Fig. 3 A).
There may well be other interreceptor interfaces in cells that
are not observed in the available crystal structures.
TABLE 3 Distances between EGF molecules and interface parameters in models of possible EGFR oligomers generated from












Back-to-back 1mox (12) 111 Increase 1107 17.3 (0.043)
Head-to-head 1mox (12) 50 Decrease (min 27 A˚) 440 3.1 (0.430)
Back-to-back 1ivo (13) 111 Increase 1315 14.0 (0.132)
Weak A:A 1ivo (13) 64 Increase 455 0.3 (0.559)
Weak B:B 1ivo (13) 46 Decrease 284 1.0 (0.749)
Head-to-back§ 1nql (15) 53 Similar 956 9.9 (0.263)
Domain II/IV interactions{ 1nql (15) 68 Similar 655 5.7 (0.366)
Perpendicular 1yy9 (73) 816 5.0 (0.417)
HER3 conformationk 1m6b (64) 1877 21.0 (0.061)
*Distances between EGF or TGFa molecules are from the ﬁrst determined amino acid residues (residues 2/3 in 1mox and residue 5 in 1ivo).
ySize of Cy3 or Cy5 dye used is ;20 A˚.
zCalculated by PISA (53).
§DG is the solvation free energy gain upon formation of the interface, as calculated by PISA. It does not include the effect of satisﬁed hydrogen bonds and salt
bridges across the interface. The p-value is the probability of getting a lower than obtained DG, if interface atoms are picked randomly from the protein
surface.
{Inactive crystallographic dimer.
kCrystal of unliganded HER3 dimer.
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DISCUSSION
Using single-pair FRET analysis of inter-EGF distances in
EGFR-EGF complexes, we have demonstrated for the ﬁrst
time to our knowledge that—in cells—EGFR ectodomains
can form at least two interfaces, both structurally different
from the back-to-back dimer arrangement which would not
show any detectable FRET. One of these interfaces places
two EGF molecules at short inter-EGF distances (,5.5 nm),
like those previously invoked by simple no-FRET/high-
FRET models employed to interpret ensemble FRET data
(22,24–26). The other interface shows EGF pairs positioned
in EGFR-EGF complexes with inter-EGF distances of ;8
nm and has not been predicted by simple no-FRET/FRET
models. The ;8 nm distances could not solely be accounted
for by a mixture of FRET states (i.e., colocalization of
quenched and unquenched donors) because they were clearly
observed for single EGF pairs, as reported by the single-step
photobleaching in donor and acceptor channels (Fig. 3, A,
lower, B, and C). Distances of ;8 nm, therefore, need to be
taken into consideration in interpretations of ensemble FRET
data. We propose that such distances represent a mixture of
conformations in the EGFR-EGF complex that were trapped
by the cell ﬁxation procedure and/or the kinetic intermediates
previously proposed (68).
We have also provided the ﬁrst evidence of the much
sought structural differences between HA and LA EGFR
complexes. The distance measured from EGF to the plasma
membrane for HA EGFR complexes is ;3.5 nm, whereas
this distance is .7 nm for LA EGFR complexes, implying
two different orientations for HA and LA ectodomains with
respect to the plasma membrane. Different orientations were
also found for HA and LA ectodomains in cells pre-ﬁxed
before exposure to EGF, showing the two different orien-
tations are independent of EGF binding. This suggests that
the EGFR ectodomain orientation must instead be regulated
by interactions between EGFR and other cellular compo-
nents (e.g., cytoskeleton (69), endocytic machinery (7), and
lipid rafts (8)). The different constitutive orientations of HA
and LA EGFR ectodomains also suggest that the ability to
selectively block EGF binding to the HA and LA EGFR
populations shown by different monoclonal anti-EGFR anti-
bodies is due to steric constraints. We speculate that the dif-
ferent ectodomain orientations could give rise to the two
afﬁnities of EGFR for EGF binding because the electrostatic
environment of the EGF-binding site is very different for the
two orientations. The HA binding site would be much closer
to the plasma membrane and therefore affected by the sur-
face and dipole membrane potentials, which are signiﬁcant
up to ;4 nm from the cell surface (70). HA EGF binding
might therefore be regulated at the cell surface by different
electrostatic and van der Waals forces.
Our single-molecule FRET results do not provide any
clear evidence for the formation of stoichiometric oligomers
larger than dimers at the sub-10-nm scale. However, because
of the ‘‘resolution gap’’ between FRET measurements (,10
nm) and the optical resolution of the microscope (;500 nm),
we cannot quantify inter-EGFR distances between 10 nm
and 500 nm in complexes observed to contain more than two
receptors (Fig. 3 A and Table 2). As ﬂuorescence spots were
observed to remain intact while slowly diffusing laterally and
given the low density of spots per image, we conclude that
EGFR groups larger than dimers must be held together by
additional interactions between these receptors and/or with
other cell structures, for example, within lipid rafts smaller
than the PSF of the microscope (8). We cannot, therefore,
rule out the possibility that the observed groups of EGFRs
are stoichiometric oligomers, as has previously been sug-
gested (24). If this is the case, our data suggest that EGFR
ectodomain interfaces showing FRET in dimers (Fig. 3 A)
are kept separated by .10 nm by their 3D ectodomain ar-
rangement within the oligomers, i.e., preventing FRET inter-
actions. Considering that the back-to-back dimer structure—
generally believed to be involved in the formation of EGFR
oligomers—would provide such a .10 nm ‘‘spacer’’ between
pairs of high-FRET ectodomains, our data would, therefore, be
consistent with previous models of EGFR oligomerization
(24,25).
In light of the growing evidence for EGFR stoichiometric
oligomerization in the form of trimers (25,31,71), tetramers
(24,26), previous models of oligomers (24,25), and the
current crystallographic evidence (Table 3), we explored the
complexes we could build that are consistent with the inter-
EGF distances and EGF/plasma membrane separation that
we measured by FRET. Fig. 6, A and B, shows a model of a
HA EGFR-EGF tetramer that incorporates a strong back-to-
back interface and two weak head-to-head interfaces. These
interfaces are both present as dimers in the crystallographic
asymmetric unit of a ligand-bound EGFR complex (12), and
the latter is consistent with the ,5.5 nm inter-EGF distances
we have measured. Unlike other weak interfaces, the head-
to-head interface has a negative solvation free energy dif-
ference (Table 3) and is particularly interesting in the context
of our FRET results because it has the antiparallel symmetry
that allows four receptors to lie ﬂat on the membrane, as
shown for HA EGFRs, while still interacting via both
interfaces. Furthermore, the back-to-back interface provides
the required .10 nm ‘‘spacer’’ between the two high-FRET
head-to-head ectodomain interfaces. We note that this ar-
rangement may, in principle, also contain any number of
EGFRs, including the trimers recently identiﬁed by gel
electrophoresis (25,71), rather than solely consisting of dimers
as proposed elsewhere (24). Fig. 3 E may be an example of
ﬁve receptors in such a complex. We therefore propose that
the combination of parallel and antiparallel interfaces in Fig.
6, A and B, reﬂects some of the ectodomain associations that
could generate EGFR oligomers in vivo but only in HAEGFR
complexes.
To model LA EGFR complexes, we placed two back-to-
back EGFR dimers side-by-side so that there are four EGFRs
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in a rectangle, each aligned perpendicularly to the membrane
(Fig. 6, C and D), as previously suggested (24). Simply
placing two rigid back-to-back crystal structures side-by-side
does not produce a good interface, because it does not take
into account any conformational changes that would have to
take place on interface formation. However, it does suggest
that if such a tetramer did exist, the distance between the
EGF N-termini along the short side of the rectangle formed
would be ;3.5 nm, comparable with the single-molecule
FRET results (Fig. 3, A and D). The requirement inferred
from FRET measurements (Fig. 5 D) that the distance from
EGF to the plasma membrane be .7 nm would also be
satisﬁed. We propose that the combination of interfaces
depicted reﬂects some of the ectodomain associations that
could generate LA EGFR tetramers in vivo.
Apart from domain II/IV interactions (Table 3), which are
only observed in inactive EGFR states, there is no crystal-
lographic evidence or models proposed that can explain the
;8 nm inter-EGF distances we ﬁrst (to our knowledge)
report here. We have suggested above that these distances
could result from conformational and/or kinetic intermedi-
ates. Work is currently underway to develop models that can
explain how these interfaces might participate in the for-
mation of EGFR-EGF complexes.
Based on ourmodel forHAEGFRcomplexes (Fig. 6,A and
B), we have produced a cartoon suggesting a possible
mechanism for HA EGFR signal transduction (Fig. 7). We
note that the resulting differences in the symmetries and
orientations of the intracellular domains, which arise from the
ectodomain interfaces and orientations identiﬁed here, pro-
vide a structural basis by which HA and LA signaling spec-
iﬁcity can be achieved. In the tetramer shown, the alternation
of back-to-back and head-to-head (parallel and antiparallel)
ectodomains leads to an inherent asymmetry bywhich nearest
ectodomain neighbors belong to a different receptor pair to
that of the nearest kinase neighbors. Kinase activation would
FIGURE 6 Model of HA and LA EGFR
complexes. (A and B) Top and side views of a
tetramer complex created through a combina-
tion of back-to-back and head-to-head interac-
tions. The ectodomains need to lie on the cell
surface for the two interactions to be able to
occur simultaneously. Each receptor is repre-
sented by a color, and EGFR domains I–IV are
labeled. Four EGF molecules are bound, one to
each receptor in the tetramer. Dye molecules
are represented by an asterisk. (C and D) Top
and side views of an EGFR tetramer generated
by placing two back-to-back dimers one behind
the other. The side views of the tetramers (B
and D) show the predicted distances between
bound EGF and the cell surface (3.5 and 8.2
nm, respectively).
FIGURE 7 Model of HA EGFR signaling complexes.
EGF bound to HA receptors in a tetramer involving a
combination of two distinct conﬁgurations, giving dis-
tances between EGF ligands and between EGF and the
plasma membrane that are consistent with our FRET data.
This conﬁguration results in a different intracellular kinase
domain arrangement, which may explain how EGFR
oligomers achieve multiple levels of signaling.
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therefore involve interactions between three receptors arranged
to allow optimal phosphorylation of the C-terminal tails as
previously described (72). This may explain the mismatch
between the twofold screw axis symmetry between ectodo-
mains of HA EGFR and threefold screw axis asymmetry of
the kinase domains, why constitutive dimers are inactive, and
how signals can be regulated by oligomerization. The current
model of active EGFR tetramers (24) is only consistent in
A431 cells with the conﬁguration of the LA EGFR popula-
tion. Their different conﬁguration, extracellularly and intra-
cellularly, to HA receptors must therefore play a role in the
exclusive ability of LA EGFRs to bind the EGF-like ligand
Epigen and in the control of evasion of ubiquitination and
downregulation (10,11).
Interestingly, in the crystal structure of the tethered ErbB3
(64), a closely related EGFR family member, the packing of
molecules also reveals an antiparallel dimer (PDB ID code
1m6b) with a strong interface (Table 3) (64). The dimer is
generated by crystal symmetry, with domain I of one mol-
ecule in contact with domain III of the other and vice versa.
This interaction creates a strong interface, burying 1877 A˚2
per receptor, and is highly favorable as shown by the large
negative DG value and a p-value close to zero. Because the
ErbB3monomers are in an inactive conformation, this arrange-
ment could point toward an antiparallel constitutive dimer.
Although the details of this interface are different from those
of the head-to-head structure of EGFR, it does suggest that
ectodomain antiparallel arrangements are possible in other
receptors. This new mode of oligomer formation, involving
interfaces with different symmetries, may therefore be gen-
erally present in interactions between all four EGFR family
members, regulate the selection of heterodimerization partners
among members of the EGFR family, and explain how sig-
nals propagate in normal and cancerous cells.
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